News | Ultrasound Imaging | November 21, 2016

Fujifilm SonoSite Showcases Comprehensive Portfolio Of Point-Of-Care Ultrasound At RSNA 2016

Fujifilm SonoSite Showcases Comprehensive Portfolio Of Point-Of-Care Ultrasound At RSNA 2016

Fujifilm SonoSite Inc., specialists in developing cutting-edge ultrasound solutions and providing world-leading education to enable point-of-care visualization access, will present its innovative portfolio of ultrasound solutions and highlight enhanced features and upgrades at the 102nd scientific assembly and annual meeting of the Radiological Society of North America (RSNA) held Nov. 27 – Dec. 2, 2016, at McCormick Center in Chicago, Ill. 

"We designed Fujifilm SonoSite products to meet the needs of a wide range of point-of-care scenarios including some of the most demanding," said Diku Mandavia, M.D., FACEP, FRCPC, chief medical officer and senior vice president, Fujifilm SonoSite Inc. and FujiFilm Medical Systems U.S.A., Inc. "Clinicians know they can trust Fujifilm technology when it comes to practical day-to-day use but also as tools that help them make rapid lifesaving decisions wherever they are — in the ED, OR or out in the field."

The following will be on exhibit and available for demonstration at RSNA Booth #6713:

SonoSite SII—Originally developed for regional anesthesia, vascular access and trauma applications, the SII empowers efficiency for clinicians through a simple, yet smart user interface that adapts to the user's imaging needs. The system is portable and can be used across multiple hospital environments, including a zero footprint option. The latest version of SII offers improved imaging technology and steep needle profiling. The SII also features DirectClear technology, a novel, patent-pending process that is now available on the rP19c and rC60xi transducers. DirectClear elevates transducer performance by increasing penetration and contrast resolution. Other new enhancements include a larger display with anti-reflection glass, greater storage capacity, updated system ports, an improved stand and armored cabling for durability.

SonoSite X-Porte—This highly portable system incorporates Extreme Definition Imaging (XDI), a breakthrough, proprietary beam-forming technology that pinpoints precision so artifact clutter is dramatically reduced and contrast resolution is greatly enhanced. The system includes a user-friendly customizable touchscreen interface as well as real-time educational visual guides and tutorials. New features and functionality include additional customized worksheets as well as the ability to take measurements and calculations on a closed exam.

SonoSite iViz—Advancing Fujifilm's integration of ultrasound with medical IT, iViz was designed with ultra-mobility in mind. It allows seamless access to learning resources and patient information, as well as the ability to store exam findings, submit reports, and consult with remote providers for near real-time assessment, making it especially suited for field use and telemedicine. As a next generation architecture and platform, iViz is the first medical visualization solution that is enabled for bi-directional EMR connectivity through the Synapse VNA. Using this option, iViz accepts patient demographics from the EMR, eliminating manual entry and saving valuable time. With just a few taps, iViz can also send patient reports to the EMR.

Vevo MD—A groundbreaking technology, Vevo MD is the world's first Ultra High Frequency ultrasound system for clinical use. The range of frequencies available (up to 70 MHz) results in unprecedented image resolution—down to 30 micrometers, which is less than half a grain of sand. With Vevo MD, clinicians can see the smallest parts of anatomy, making it an ideal tool for imaging infants, identifying detecting tiny suspicious lesions, or monitoring subtle changes in blood flow in major arteries.

See Vevo MD in Action, Learn the Latest About Ultrasound

For the first time ever, Fujifilm will be performing live model scanning with Vevo MD in Booth #6713. This is a rare and exciting opportunity for RSNA attendees to see the world's first ultra high-frequency ultrasound system for clinical use in action—on real people. Due to RSNA restrictions, onsite imaging scans will be limited to the head, neck, upper abdomen, and extremities.

In addition, attendees are encouraged to visit Fujifilm's In-Booth Healthcare Theater which will include two daily presentations on ultrasound topics: Ultra-High Frequency: A New Mode in Imaging and Ultra-Mobility in Imaging.

Register for a product demonstration at RSNA 2016 here: http://rsna.fujimed.com

For more information: www.sonosite.com.

Related Content

MRI Targeted biopsy is performed using cognitive fusion more easily with anatomical guidance based on the radiology report. MRI targets can be identified quickly in real-time along with micro-ultrasound targets, which may have been missed on MRI.

MRI Targeted biopsy is performed using cognitive fusion more easily with anatomical guidance based on the radiology report. MRI targets can be identified quickly in real-time along with micro-ultrasound targets, which may have been missed on MRI. Image courtesy of Exact Imaging

Feature | Prostate Cancer | January 20, 2021 | By Brian Wodlinger, Ph.D.
Historically when a patient had an elevated PSA (prostate specific antigen) test their urologist would take the next
Previously approved by FDA in the USA, MyLab X8 expands the reach of the MyLab Ultrasound Product Line with a fully featured premium imaging solution, integrating the latest technologies and delivering superior image quality without compromising workflow or efficiency.
News | Ultrasound Imaging | January 20, 2021
January 20, 2021 — Esaote North America announces that the...
Jeff Elias, MD, is a neurosurgeon at UVA Health and a pioneer in the field of focused ultrasound.

Jeff Elias, MD, is a neurosurgeon at UVA Health and a pioneer in the field of focused ultrasound. Image courtesy of UVA Health

News | Focused Ultrasound Therapy | January 08, 2021
January 8, 2021 — A scalpel-free alternative to brain surgery has the potential to benefit people with...
Ultromics will offer its artificial intelligence driven EchoGo Pro as a stress-echo module in the EchoGo suite alongside EchoGo Core, its AI solution for automated systolic function and strain analysis. The EchoGo suite is a cloud-based service that uses artificial intelligence to fully automate the pathway to diagnosis, providing near-instant reports for clinicians without any need for physical software on site. #AI #AIhealthcare #AIecho

Ultromics will offer its artificial intelligence driven EchoGo Pro as a stress-echo module in the EchoGo suite alongside EchoGo Core, its AI solution for automated systolic function and strain analysis. The EchoGo suite is a cloud-based service that uses artificial intelligence to fully automate the pathway to diagnosis, providing near-instant reports for clinicians without any need for physical software on site.

News | Artificial Intelligence | January 06, 2021
January 6, 2021 — The U.S.
New software-based application helps clinicians visualize breast anatomy and provides detailed characterization of lesions
News | Breast Imaging | December 17, 2020
December 17, 2020 — Hologic, Inc.
For some, COVID-19 can result in severe pneumonia or even death, while others remain purely asymptomatic. A diagnostic tool could help physicians predict if a patient with COVID-19 will worsen.

Using 14 points in the lungs, researchers looked for abnormalities and assigned each spot a score out of 3 based on its severity. Adding up all the points, they found the total lung ultrasound score was higher for those who had a worsening outcome of COVID-19. Image courtesy of Umberto Sabatini

News | Coronavirus (COVID-19) | December 11, 2020
December 11, 2020 — For some, COVID-19 can resul
An MR image of a patient in their early 20s shows nerve injury (highlighted in yellow) of the left brachial plexus in the neck. The patient experienced left arm weakness and pain after recovering from COVID-19 respiratory illness, which prompted them to see their primary care physician. As a result of the MRI findings, the patient was referred to the COVID-19 neurology clinic for treatment. Image courtesy of Northwestern University

An MR image of a patient in their early 20s shows nerve injury (highlighted in yellow) of the left brachial plexus in the neck. The patient experienced left arm weakness and pain after recovering from COVID-19 respiratory illness, which prompted them to see their primary care physician. As a result of the MRI findings, the patient was referred to the COVID-19 neurology clinic for treatment. Image courtesy of Northwestern University

News | Coronavirus (COVID-19) | December 08, 2020
December 8, 2020 — After recovering from COVID-19
Samsung to highlight its medical imaging portfolio with its latest radiology innovations in ultrasound, digital radiography and mobile computed tomography
News | Radiology Imaging | December 02, 2020
December 2, 2020 — Samsung Electronics Co., Ltd.